The UM CURE 2020 Consortium 

Uveal Melanoma (UM) is a rare intraocular disease and while the primary tumour can often be treated effectively, there is currently no effective treatment for its metastases. The overall goal of the UM Cure 2020 consortium is to combine the efforts of several European Centres of Excellence in clinical ocular oncology and basic research with patient organisations to develop new therapeutic approaches to treat metastatic UM, and share this new knowledge efficiently. to get more information on this project pop over to their website